About this trial
This study aims to validate MBT as an effective and viable intervention for implementation in public health services, with the potential to directly impact suicide prevention policies in the region.
Eligibility criteria
Qualifiers
Age and consent
Presence of suicidal ideation or active behavior in the last month, assessed using the C-SSRS (e.g., intentional ideation, plan, or preparatory behavior)
Depressive or anxious symptoms (Score ≥ 10 on the PHQ-9, indicating at least moderate depressive symptoms, or Score ≥ 10 on the GAD-7, suggesting clinically significant anxiety.)
Availability and commitment to participate in the full assessment using all the aforementioned scales.
Disqualifiers
Clinical Safety (exclude and refer immediately)
Imminent suicide risk according to the C-SSRS (e.g., attempt within the last 7 days, current intentional plan, access to lethal means, and low ambivalence).
PHQ-9 item 9 = 3 ("almost every day") with clinical corroboration of imminent risk.
Current self-harm with lethality/high-harm moderator requiring acute restraint.
Trial design
Treatments tested in this trial
- Mentalization-Based Therapy (MBT)
- Treatment as Usual (TAU)